US20150093839A1 - Methods and systems for detection of target and applications thereof - Google Patents

Methods and systems for detection of target and applications thereof Download PDF

Info

Publication number
US20150093839A1
US20150093839A1 US14/043,895 US201314043895A US2015093839A1 US 20150093839 A1 US20150093839 A1 US 20150093839A1 US 201314043895 A US201314043895 A US 201314043895A US 2015093839 A1 US2015093839 A1 US 2015093839A1
Authority
US
United States
Prior art keywords
target
binding
event
binding element
elution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/043,895
Inventor
Radislav Alexandrovich Potyrailo
Andrew David Pris
Nandini Nagraj
Anthony John Murray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Co filed Critical General Electric Co
Priority to US14/043,895 priority Critical patent/US20150093839A1/en
Assigned to GENERAL ELECTRIC COMPANY reassignment GENERAL ELECTRIC COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MURRAY, ANTHONY JOHN, NAGRAJ, NANDINI, POTYRAILO, RADISLAV ALEXANDROVICH, PRIS, ANDREW DAVID
Publication of US20150093839A1 publication Critical patent/US20150093839A1/en
Priority to US15/465,970 priority patent/US10989709B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements

Definitions

  • the invention generally relates to methods and systems for target detection using nucleic acid based binding elements capable of undergoing repeated regeneration cycles.
  • Binding elements including affinity ligands, such as antibodies are valued for their high selectivity and affinity, however, the stability of the molecules for their size and complex structure is an issue.
  • Engineered protein binders have proved to be successful as affinity ligands for their small size, stability, and ease of synthesis in microbial production systems, however these binders might be unsuitable for therapeutic applications because of their potential immunogenicity. Additionally the protein binders are expensive, and are not suitable for repeated use.
  • Alternate binding elements based on nucleic acids, such as DNA or RNA have been developed for target specific binding.
  • Binding elements that offer higher stability, selectivity and specificity towards the target and provide solutions to fit both the single-use and multiple-use paradigms are highly desirable. Moreover, reusability of the binding elements for detection of multiple targets is a current need, which may reduce the expense of the detection process.
  • a method of recovering a target from a sample comprises providing a substrate coupled binding element, wherein the binding element is immobilized on a solid support; adding the sample comprising the target to the substrate coupled binding element to form a substrate coupled binding element-target complex; washing the substrate coupled binding element-target complex; and eluting the target from the substrate coupled binding element-target complex.
  • a method for reversible detection of a target comprises immobilizing one or more binding elements on a sensor surface, contacting a sample comprising an unknown concentration of the target to the binding elements on the sensor surface to form a binding element-target complex in a target binding event; detecting the target-binding event with a detector to generate a detection signal; eluting the target from the binding element-target complex in an elution event; applying a regeneration solution to complete the removal of the target bound to the binding element in a regeneration event; determining a number of the target-binding event, the elution event, regeneration event or combinations thereof; and applying a correction to the detection signal based on the number of the binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target over at least 100 bind/release cycles.
  • a method for reversible detection of a target and quantitation of a target concentration in a sample comprises immobilizing one or more binding elements on a sensor surface, contacting a sample comprising the target to the binding elements to form a binding element-target complex in a target binding event; detecting the target-binding event with a detector to generate a detection signal; eluting the target from the binding element-target complex in an elution event; applying a regeneration solution to regenerate the binding element in a regeneration event; determining a number of the target binding event, the elution event, the regeneration event or combinations thereof; and applying a correction to the detection signal based on the number of the target binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target and quantitation of the target concentration over at least 100 bind/release cycles.
  • the system comprises a sample holder comprising one or more binding elements immobilized on a surface, wherein the surface is configured to load a sample comprising the target to complete a binding event forming a binding element-target complex; an inlet to supply at least a first solution to wash the binding element-target complex; an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event; a detector to generate a detection signal in proportion to the concentration of the target in the sample; and a processor for calibrating performance of the system for reversible operation of the immobilized binding elements.
  • a system for reversible detection of a target comprises a sample holder comprising one or more binding elements immobilized on a surface of the sample holder, wherein the surface is configured to load a sample comprising the target to form a binding element-target complex to complete a binding event; an inlet to supply at least a first solution to wash the binding element-target complex to complete a washing event; an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event; a target-concentration detector to generate a detection signal in proportion to a concentration of the target in the sample; a counter for counting the binding event, washing event, elution event or combinations thereof; and a processor for calibrating a performance of the system based on a number of prior performed bind-release cycles for accurate reversible operation of the immobilized binding elements.
  • FIG. 1 is a flow chart showing a method for target detection using binding elements in accordance with one embodiment of the invention.
  • FIG. 2 is a schematic diagram showing a system for target detection using binding elements in accordance with one embodiment of the invention.
  • FIG. 3 is a schematic representation of a process flow diagram using the system, wherein the system performs multiple cycles of the detection in accordance with one embodiment of the invention.
  • FIG. 4 is a graph showing binding of thrombin followed by regeneration of the thrombin specific binding element in accordance with one embodiment of the invention.
  • FIG. 5 is a graph showing high stability of the binding constant K d for Thrombin during 365 bind/release cycles of reversible operation as a function of performed bind/release cycles.
  • FIG. 6 is a histogram showing the binding constant K d for thrombin during 365 bind/release cycles.
  • FIG. 7 is a series of graphs showing detection of thrombin using varying concentrations over 365 bind/release cycles for reversible operation using immobilized thrombin specific binding element.
  • FIG. 8 is a graph showing detection of thrombin using corrected sensor response.
  • FIG. 9 is a graph showing binding of thrombin followed by regeneration of the thrombin specific binding element using deionized water in accordance with one embodiment of the invention.
  • binding cycle refers to the sequence of events that include introducing a sample comprising a target to a surface comprising binding elements immobilized onto the surface, such as a sensor surface, binding the target to the binding element to form a binding element target complex, applying a washing solution to the a binding element target complex, applying an elution and/or applying a regeneration solution to the binding element target complex to elute the target and regenerate the binding element for subsequent use.
  • binding/release cycle or “cycles: are interchangeably used hereinafter.
  • nucleotide or “nucleotide base” refers to a nucleoside phosphate.
  • the term includes, but is not limited to, a natural nucleotide, a synthetic nucleotide, a modified nucleotide, or a surrogate replacement moiety (e.g., inosine).
  • the nucleoside phosphate may be a nucleoside monophosphate, a nucleoside diphosphate or a nucleoside triphosphate.
  • the sugar moiety in the nucleoside phosphate may be a pentose sugar, such as ribose, and the phosphate esterification site may correspond to the hydroxyl group attached to the C-5 position of the pentose sugar of the nucleoside.
  • a nucleotide may be, but is not limited to, a deoxyribonucleotide triphosphate (dNTP) or a ribonucleotide triphosphate (NTP).
  • the nucleotides may be represented using alphabetical letters, for example, A denotes adenosine (e.g., a nucleotide containing the nucleobase, adenine), C denotes cytosine, G denotes guano sine, and T denotes thymidine.
  • A denotes adenosine (e.g., a nucleotide containing the nucleobase, adenine)
  • C denotes cytosine
  • G denotes guano sine
  • T denotes thymidine.
  • oligonucleotide refers to oligomers of nucleotides or derivatives thereof.
  • nucleic acid refers to polymers of nucleotides or derivatives thereof.
  • sequence refers to a nucleotide sequence of an oligonucleotide or a nucleic acid. Throughout the specification, whenever an oligonucleotide/nucleic acid is represented by a sequence of letters, the nucleotides are in 5′ ⁇ 3′ order from left to right.
  • the oligonucleotides/nucleic acids may be a DNA, an RNA, or their analogues (e.g., uracil, inosine analogue).
  • the oligonucleotides or nucleic acids may also include modified bases and/or backbones (e.g., modified phosphate linkage such as thiophosphate or modified sugar moiety, such as locked nucleic acid).
  • modified bases and/or backbones e.g., modified phosphate linkage such as thiophosphate or modified sugar moiety, such as locked nucleic acid.
  • Non-limiting examples of synthetic backbones that confer stability and/or other advantages to the nucleic acids may include phosphorothioate linkages, peptide nucleic acid, locked nucleic acid, xylose nucleic acid, or analogues thereof.
  • the oligonucleotide refers to a linear oligonucleotide that may include 5 to 1000 nucleotides. Both the upper and lower limits of the length of the oligonucleotide are empirically determined. The lower limit on oligonucleotide length is the minimum length that is required to form a transient complex upon binding with the target molecule under desired reaction conditions. Very short oligonucleotides (usually less than 3-4 nucleotides long) do not form thermodynamically stable complex with target molecule under such conditions. The upper limit of oligonucleotide length is the maximum length that the linear oligonucleotide sequence can be accurately amplified (usually around 1000-5000 nucleotides).
  • the oligonucleotides may also be interchangeably referred to herein as “oligomers” or “short oligomers”.
  • the oligonucleotide may be an RNA sequence, a DNA sequence, or a chimeric sequence comprising different bases.
  • the oligonucleotide may contain natural, synthetic, or modified nucleotides. Generally, suitable oligonucleotide lengths are in the range of 4-5000 nucleotides, more specifically, between 4-100 nucleotides long.
  • the oligonucleotide refers to a linear oligonucleotide that may include 5 to 1000 nucleotides.
  • the upper limit of oligonucleotide length may be the maximum length that the linear oligonucleotide sequence be accurately amplified (usually around 1000-5000 nucleotides).
  • Suitable oligonucleotide lengths may be in the range of 4-5000 nucleotides, or between 4-100 nucleotides long.
  • target molecule refers to a molecule that is of interest to determine its concentration in the analyzed sample.
  • the target molecule may be an organic molecule, an inorganic molecule, a biological molecule, a synthetic molecule or combinations thereof.
  • the target molecule may be a protein, a post-translationally modified protein, a peptide, a carbohydrate, a drug, a carrier, a small molecule, an adapter, an epitope or combinations thereof.
  • the target molecule may comprise a single entity or a multiple entity.
  • a cell-surface protein is a single entity, which has only one binding motif and that can be a single entity target.
  • the target molecule may comprise a multiple entity, such as, one or more cell-surface proteins have epitopes that are associated with multiple single entities.
  • the target may be a specific combination of epitopes, such as, a multi-subunit protein complex or a section of a cell surface comprising the multi-subunit protein.
  • the non-limiting examples of a multiple entity include surface of a cell, surface of a virus, surface of a tissue, at least two outer regions of a folded polymer molecule, at least two outer regions of a folded biopolymer molecule, a surface of an inorganic amorphous material, and a surface of an inorganic crystalline material.
  • the binding element for such a target has a single binding motif or more than one binding motif.
  • binding element refers to herein as an oligonucleotide-based component that efficiently binds to a target molecule through one or more binding sites through different types of interactions, including but are not limited to, hydrophobic, Van der Waals interactions and hydrogen bonding.
  • the binding element may include an aptamer, such as deoxyribonucleic acid (DNA) aptamer, ribonucleic acid (RNA) aptamer or peptide nucleic acid (PNA) aptamer.
  • DNA deoxyribonucleic acid
  • RNA ribonucleic acid
  • PNA peptide nucleic acid
  • a method of recovering a target from a sample comprises providing a substrate coupled binding element, wherein the binding element is immobilized on a solid support; adding the sample comprising the target to the substrate coupled binding element to form a substrate coupled binding element-target complex; washing the substrate coupled binding element-target complex; and eluting the target from the substrate coupled binding element-target complex.
  • the target molecule and the binding element are in contact, which enable the binding elements to bind to the target molecules and form a substrate coupled binding element-target complex.
  • the target molecule and the binding element are mixed thoroughly to form a binding element-target complex in a first solution.
  • the target molecules and the binding elements are mixed in the first solution using different mixing techniques, such as by pipetting up and down, vortexing, mild shaking, waving or stirring.
  • the target molecules and the binding element are incubated at a specific temperature without any mixing or agitation.
  • the method comprises addition of the sample to the binding element, wherein the target and the binding element may be in contact to each other, which results in formation of a substrate coupled binding element-target complex.
  • the plurality of binding elements has affinity for the target molecules.
  • the method comprises forming a binding element-target complex.
  • binding element-target complex refers to a complex wherein a binding element is bound to a target molecule.
  • the addition of substrate coupled binding element to the target forms a substrate coupled binding element-target complex.
  • binding element-target complex or “complex” is interchangeably used hereinafter.
  • the first solution comprises the substrate coupled binding element-target complex, excess unbound target, other molecules and impurities. As mentioned, the “other molecules”, these molecules may have structural similarity with the target.
  • the affinity of the binding element for the target molecules may enhance the binding efficiency of the binding element to the target.
  • the binding elements are bound to the target molecules by ionic interaction, H-bonding, Vander Waal's forces or combinations thereof.
  • the binding element target complex is stabilized by adding a reaction buffer to the mixture.
  • the binding element-target complex comprises the binding element and the target in 1:1 ratio.
  • the binding element is immobilized on a solid support.
  • the method comprises providing a binding element immobilized on a solid support, adding a sample comprising a target to the substrate coupled binding element to form a binding element-target complex that is immobilized to the solid support.
  • the binding element-target complex is washed followed by elution of the target from the binding element-target complex.
  • the binding element immobilized on a solid support is recycled for multiple times.
  • the binding element immobilized on a solid support may be recycled for 2 to 100,000 times, in some other embodiments, the binding element immobilized on a solid support is recycled for 2 to 100 times.
  • the structural integrity of the substrate coupled binding element remains intact, which ensures binding efficiency of the binding element to the target for multiple cycles.
  • the term, “bind/release cycle” or “cycles” are used herein interchangeably to describe a complete event that is combination of the binding event, washing event, the elution event and regeneration event.
  • the complete process refers to a complete cycle.
  • the number of cycles can be repeated.
  • the substrate may also maintain the structural integrity for multiple uses.
  • the solid support may be a surface of any solid material or a substance.
  • the non-limiting examples of solid support may include a glass slide, a sensor chip, a petri-plate, a petri-dish, a test tube, a beaker, a container, a solid matrix, a hydrogel, a membrane.
  • a solid material with an exposed surface may be used as a solid support, for example, a metal sheet, a glass slide or a plastic plate.
  • the solid support may be a component of a system, wherein a surface of the component may function as a solid support for holding the substrate coupled binding elements.
  • the binding element-target complex is washed with a washing solution.
  • the “washing solution” may refer to a solution that provides a washing condition which does not destabilize the binding element-target complex.
  • the washing solution may be selected depending on the binding element or the target, and the stability of the binding element-target complex.
  • the washing may be performed when the complex is bound to a solid support.
  • the washing may remove un-bound or non-specifically bound molecules present in the sample, or any impurities present in the solution comprising the binding element-target complex.
  • the washing comprises repeated washing cycles. Repeated washings may ensure presence of only specifically bound target to the binding element.
  • washing solution is used for washing the complex attached to the solid support.
  • the post-wash liquid may be removed to eliminate any un-bound target, non-specifically bound other molecules or any impurities.
  • the method further comprises dissociating and eluting the target from the complex using an “elution solution”.
  • an ‘elution solution’ may refer to a solution that elutes the target from the binding element-target complex using various methods.
  • the elution is achieved by one or more of the methods selected from: re-constituting the substrate coupled binding element-target complex in a solution to dissociate the target, washing the complex with either a buffer with a high ionic strength or using mild conditions, inducing a conformational change to the binding element or binding element-target complex.
  • the binding element-target complex may be dissociated under mild conditions
  • the term “mild condition” refers to herein as a condition which causes minimum structural change of the binding element so that it can release the target, however the condition ensures minimum or no structural or functional change to the target.
  • the mild conditions allow recovery of the target in an un-denatured form with minimal aggregation or unfolding.
  • the mild condition causes a conformational change to the binding element and retains the intact structure and function of the target.
  • the mild condition causes a conformational change to the binding element; one or more solutions may be added to the binding elements to regenerate the actual structure of the binding element. These solutions are referred to herein, as a “regeneration solution”.
  • the ‘regeneration solution’ may be used for regenerating the binding element under mild conditions.
  • the regeneration solution regenerates the binding elements by recovering the actual structure and function.
  • the regeneration solution also functions as elution solution, as the solution also elutes the target.
  • the regeneration solution is used for washing the complex and elutes the target.
  • the solution regenerates the binding element during elution of target or after elution of the target.
  • the requirement of elution and regeneration is different and that depends on the selection of binding element or target.
  • the regeneration solution only recovers the structure or function of the binding element but not elute the target.
  • the regeneration solution which helps to regain the actual structure of the binding element after conformational change to the binding element may include, but are not limited to, a buffer with a high ionic strength, a diluted base, a salt solution or deionized water, guanidinium hydrochloride, sodium hydroxide, sodium chloride, and mixtures of sodium hydroxide and sodium chloride.
  • the change when the mild condition causes minimum structural change to the target, the change is a reversible conformational change.
  • the target regains its original structure after recovery.
  • the conditions are selected that favor conformational change to the nucleic acid binding element however, maintains the tertiary structure and function of the target.
  • the mild conditions allow for reuse of the binding element.
  • the regeneration solution is used to regenerate the binding element for multiple uses. In case of binding element used for detection or sensor applications, easy removal of analyte target allows reuse of the sensor, preferably many times over with minimal loss of binding capacity or destruction of the binding element. In these embodiments, minimal loss of binding capacity may also be recovered using one or more of the regeneration solutions.
  • the mild condition may include, use of deionized water, weak bases, salts or chelators.
  • the deionized water may un-shield the charge on the phosphate backbone of nucleic acids (such as DNA) and hindering secondary structure formation.
  • dilute base such as 0.1-50 mM may also be used to reduce secondary structure of the nucleic acids.
  • NaCl with a concentration of 1M or greater may also be used for effectively reducing ionic interactions.
  • the structure of the binding element is stabilized by metal ions, wherein the binding element may be destabilized using a metal chelator.
  • a liquid with low ionic strength such as deionized water, is used to dissociate the target molecule.
  • a liquid with low ionic strength is desired as the liquid helps in efficient downstream purification or detection; for example buffer exchange.
  • the target in the sample may be concentrated by adding the sample to the binding element bound to the solid surface, purified from non-target molecules by using a washing solution and eluted from the binding element bound to the solid surface by water, low ionic strength solution or other mild conditions.
  • the target may further be detected downstream of the binding element bound to the solid surface.
  • Conditions for elution of the target from the first binding element may retain the binding ability of the target to the downstream binding element.
  • the “downstream” is defined herein, as the second binding element positioned after the first binding element in accordance to the sample flow path.
  • Detection means may include either the same or different binding element bound to a solid surface detection device. In some embodiments, different sets of binding elements are used for detection which may increase the selectivity for the target. Further, water or low ionic strength elution conditions are used for eluting the target from the binding element following pre-concentration step.
  • the elution may cause structural change to the binding element to release the target.
  • the elution method ensures a minimum or no structural or functional change to the target.
  • a conformational change is induced to the binding element to release the target, wherein the target retains the intact structure and function.
  • a minimum structural change may result in the target, wherein the change is a reversible conformational change.
  • the target regains its original structure after recovery and re-constitution.
  • a target such as a protein has a minimum conformational change during recovery with water or a buffer with low ionic strength. The protein target regains its original structure and function, when the target is reconstituted in a buffer with desired ionic strength.
  • the binding element is coupled to a substrate, wherein the substrate comprises a polymer, a protein, a peptide, a carbohydrate, a small molecule or combinations thereof.
  • the substrate comprises a stimuli-responsive polymer.
  • the stimuli-responsive polymer may comprise a thermo-responsive polymer, a pH responsive polymer, a pressure responsive polymer, a humidity responsive polymer, an ionic strength responsive polymer, a light responsive polymer or combinations thereof.
  • a nonlimiting example of a stimuli-responsive polymer is a hydrogel such as dextran.
  • the substrate is a tag or a linker, which includes, but are not limited to, a streptavidin coated bead, a histidine tag, a glutathione S-transferase (GST) tag, a maltose binding protein (MBP) tag, a fusion comprising an antibody Fc region, a bifunctional reagent linker, or a linker comprising biotin.
  • the substrate comprises a polymer.
  • the substrate comprises a stimuli responsive polymer.
  • the substrate is a thermo responsive polymer, a pH responsive polymer, a light responsive polymer or combinations thereof.
  • the substrate comprises dual responsive polymer, such as a thermo responsive polymer, which is also responsive to pH.
  • the substrate is a sensor surface.
  • the sensor surface may include, but are not limited to, glass, quartz, polymer, gold, platinum, nanoparticle surface, nanotube surface, or nanorod surface.
  • the sensor is employed to detect the binding events, elution events or combinations thereof and ensure reversible binding/release cycles.
  • the method is employed for reversible detection of a target.
  • the method comprises immobilizing one or more binding elements on a sensor surface, followed by contacting a sample comprising the target to the binding elements on the sensor surface. The contact between binding elements and target ensures forming a binding element-target complex in a target binding event.
  • the sensor may comprise a detector for detecting the target-binding event to generate a detection signal. The detector may provide the information about the concentration of the target in the sample.
  • the target is eluted from the binding element-target complex in an elution event; and the sensor determines a number of the target-binding event, the elution event or combinations thereof as counted from the beginning of the usage of the sensor surface followed by applying a correction to the detection signal based on the number of the binding event, the elution event or combinations thereof during the reversible detection of the target to improve accuracy of quantitation of target concentration over at least 100 bind/release cycles.
  • a method for reversible detection of a target and quantitation of a target concentration in a sample comprises immobilizing one or more binding elements on a sensor surface and contacting a sample comprising the target to the binding elements to form a binding element-target complex in a target binding event.
  • the target binding event is followed by detection of the target-binding event with a detector to generate a detection signal in proportion to the concentration of the target in the sample and eluting the target from the binding element-target complex in an elution event.
  • a regeneration solution is further applied to complete the removal of the target bound to the binding element and to regenerate the binding element in a regeneration event, determining a number of the target binding event, the elution event, the regeneration event or combinations thereof as counted from the beginning of the usage of the sensor surface. After these, a correction is applied to the detection signal based on the number of the target binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target to accurately quantify the target concentration over at least 100 bind/release cycles.
  • the target molecule may be an organic molecule, an inorganic molecule, a biological molecule, a synthetic molecule or combinations thereof.
  • the target molecule may be a protein, a post-translationally modified protein, a peptide, a carbohydrate, a drug, a carrier, a small molecule, an adapter, a virus, a cell or combinations thereof.
  • carrier refers to a compound that may attach to one or more drug, protein, peptide, carbohydrate, lipid, genetic material or small molecule for targeted delivery and controlled release.
  • the carrier may include a synthetic compound or a natural compound isolated from different sources.
  • the carrier may be a nanoparticle.
  • the target molecule is a protein or peptide.
  • the target molecule is thrombin.
  • the target molecules may be present in a solution, an extract or a formulation, which may be present in a sample at a concentration, ranged between 1 pM and 1 mM.
  • the binding elements function as affinity ligands and are selected for high affinity binding to molecular targets, wherein the oligomers are selected for synthesizing binding elements.
  • the binding element is an oligonucleotide sequence, a DNA sequence, an RNA sequence, a PNA sequence, a peptide sequence or combinations thereof.
  • the binding element may comprise a protein binding sequence or one or more tandem repeat sequences or one or more protein binding sequences.
  • the binding elements are ranging between 15-60 nucleotides in length.
  • the binding element may include substitutions on the base portion of DNA to enhance hydrophobic interactions with target molecules.
  • the binding element comprises a DNA aptamer, which is attractive for its pH and thermal stability, small size ( ⁇ 13 kDa), and high binding efficiency.
  • DNA aptamers may be considered as an efficient affinity binder in the context of downstream processing.
  • the ease of binding element synthesis may be an additional benefit, since it allows synthesizing a less expensive binding element compared to its protein-based counterparts, in addition to reproducibility in synthesis process.
  • a further favorable characteristic of DNA binding element is easy manipulation that disrupts the secondary structure of the binding element which leads to dissociation of the target from the binding element, enabling recovery of the target molecule using mild elution conditions.
  • FIG. 1 is a flow chart illustrating an exemplary embodiment of a method 30 for selecting a specific target 34 using binding element 32 immobilized on a solid support.
  • some of the steps may be performed simultaneously or in different order.
  • one or more steps may be added to the flow chart. Nonlimiting examples of these steps include detecting the concentration of the target bound to the binding element immobilized on a solid support and counting the number of the target binding events, the number of elution events as counted from the beginning of the usage of the solid support.
  • the flow chart of FIG. 1 includes the step of adding a sample comprising a target 34 to the binding element 32 to form a binding element-target complex 36 .
  • the binding element-target complex 36 is washed to recover purified binding element-target complex 40 , wherein the impurities 38 are removed. The washing is followed by elution of the target 42 from the binding element 32 immobilized on a solid support.
  • the solid support immobilized binding element is couples to a substrate or a linker. In one or more embodiments of the method, the binding element 32 immobilized on a solid support is recycled for repeated use.
  • FIG. 2 An embodiment of a system for reversible detection of a target is provided herein in FIG. 2 , wherein the system comprises a sample holder 50 with a fluidic path comprising a sensor chip 52 with one or more binding elements immobilized on a surface of the sensor chip 54 . If a sample comprising a target is added to the surface of the sensor chip 54 , a target-binding element complex formed and bound to the sensor chip 56 .
  • the system further comprises a target concentration detector 58 to detect the sensor signal level upon target binding events.
  • the system further comprises one or more inlets 60 to supply at least one washing or elution solution and samples comprising an unknown concentration of the target.
  • a sample comprising the unknown concentration of the target is applied to the sensor via system inlet 60 .
  • a washing solution and an eluting solution are also supplied through the system inlet 60 for washing or elution, respectively.
  • a regeneration solution is applied to regenerate the binding element.
  • the system further comprises an outlet 62 for removing post wash liquid.
  • the system also comprises a counter 64 and a processor 66 .
  • the system allows binding of the target to the surface-immobilized binding elements followed by release of the specifically bound target, wherein the binding/release cycle may be repeated for multiple times.
  • the lines with arrows in FIG. 2 connecting the individual components illustrate the electrical or fluidic relations between the different components of the system.
  • the system comprises at least two sensing regions with immobilized binding elements, where each region contains a different type of the immobilized binding elements.
  • the sample with unknown concentration of the target is sequentially or in parallel introduced to each of the sensing regions.
  • the sequential or parallel operation with at least two sensing regions provides the improved selectivity of determination of target binding.
  • the surface is configured to load a sample comprising the target to complete a binding event forming a binding element-target complex.
  • the term “configured to” refers to structure or configuration of the surface, wherein one or more binding elements are attached to the surface.
  • the term “immobilized” refers to herein as the binding elements are attached to the surface, such that the binding elements are tightly bound to the surface.
  • the binding elements may have minimum possibility to detach from the surface during system operation.
  • the attachment of the binding elements to the surface is achieved by using known techniques with nonlimiting examples that include a covalent attachment using thiol, amine, or hydroxysuccinimidyl functionalization and an attachment using streptavidin-biotin immobilization chemistry.
  • the binding elements are immobilized on the surface through one or more substrates.
  • the substrate may include a polymer, a metal, a cellulose, a glass, a peptide, a carbohydrate or combinations thereof.
  • the embodiments of the system further comprise an inlet 60 to supply a first solution to wash the binding element-target complex.
  • the system also comprises another inlet to supply a second solution to elute the target from the binding element-target complex to complete an elution event.
  • the system comprises a single inlet 60 that supplies both the first solution and the second solution, depending on requirement.
  • the system comprises a valve near the inlet, and the inlet may be connected to two different reservoirs, one contains first solution and the other contains second solution.
  • the system also comprises an inlet that supplies a regeneration solution (or regeneration solution) that is applied to regenerate the binding element. A regeneration solution changes the conformation of the binding element that allows releasing the bound target.
  • the system may also comprise a controller, that controls the valve and release the required solution to the system during the binding or release cycle.
  • the system may further comprise one or more chambers configured to hold one or more solutions, such as a first solution or a second solution.
  • the system may further comprise a collection chamber for collecting the target after elution. As noted, one or more solutions may be used, for example when the process requires washing under different conditions to achieve a fast washing or second washing.
  • the system may further comprise additional chambers configured to hold additional solutions.
  • the system may further comprise specific environmental controllers, such as a heating element or a UV light source.
  • the system further comprises a target-concentration detector 58 , wherein the detector 58 detects complete binding event.
  • a target-concentration detector 58 measures the concentration of the target that may be bound to the immobilized binding element.
  • Nonlimiting examples of such a target-concentration detector include optical detector, electronic detector, electrochemical detector, gravimetric detector, mechanical detector, plasmonic detector, impedance detector, acoustic-wave detector, or any other detector known in the art.
  • the system further comprises a counter 64 for detecting, counting and logging the number of the binding events, the elution event or combinations thereof as counted from the beginning of the usage of the sensor surface for reversible operation of the binding element.
  • a counter 64 is an electronic circuit that counts events of operating the target-concentration detector and performing washing steps.
  • a washing event and an elution event are different.
  • a washing event is wash with a buffer that maintains binding of target to the binding element, wherein the wash buffer may be similar buffer that used to select the binding element. Washing is included to remove non-targets that are either physically entrapped or non-specifically bound non-targets.
  • the solutions are used to dissociate the target from the binding element.
  • the solutions generally used for elution may be different from the solutions used to select the binding element for the target, such as, water, solution with low ionic strength, solution of dilute base (0.1-50 mM), or solution comprising chelators, chaotrope or salt used for washing solution.
  • the embodiments of the system also comprise a processor 66 for calibrating performance of the system for reversible operation of the immobilized binding elements.
  • the processor 66 may provide a dissociation constant of the binding elements immobilized on the surface after each elution event.
  • the processor 66 may further analyze a sensor response value for further correction.
  • the processor may also store the sensor calibrations based on the tested target concentrations and the number of bind/release cycles for the sensor.
  • the system comprises a counter 64 which is synchronized with the processor 66 and compensates any loss of binding capacity.
  • the counter 64 together with the processor 66 allows for compensation of any loss of binding capacity of the sensor chip with the immobilized binding element and preserves the accuracy of the determinations of the bound target upon multiple operation cycles of the sensor.
  • the compensation of the loss of binding capacity of the sensor chip with the immobilized binding element may be performed by the prior determination of the loss of binding capacity of the sensor chip with the immobilized binding element during the calibration routines, determination of the mathematical functional relationship between the loss of binding capacity of the sensor chip with the immobilized binding element and the number of the operation cycle and storing the mathematical functional relationship in the memory of the processor.
  • FIG. 3 shows an exemplary embodiment of a process flow diagram using the system, wherein the system performs multiple cycles of the detection.
  • a system for reversible detection of a target comprises a sample holder comprising one or more binding elements immobilized on a surface 70 , as shown in FIG. 3 .
  • the binding elements are activated using a buffer or water, forming activated binding elements 72 .
  • the surface is configured to load a sample comprising the target 74 to complete a binding event. The binding event results in forming a binding element-target complex 76 .
  • the system further comprises an inlet to supply at least a first solution to wash the binding element-target complex and an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event.
  • the binding elements are deactivated, 78 .
  • the deactivated binding elements release the target 74 .
  • the system may further comprise a target-concentration detector 58 to measure the concentration of the target that may be bound to the immobilized binding element.
  • a counter may be present in the system for counting the binding event, elution events or combinations thereof as counted from the beginning of the usage of the surface.
  • the system may further comprise a processor for calibrating 80 performance of the system based on the number of prior performed bind/release cycles for an accurate reversible operation of the immobilized binding elements ( FIG. 3 ).
  • the sensor surface upon reversible operation of the sensor comprising binding elements immobilized on the sensor surface, the sensor surface experience degradation.
  • degradation refers to a spontaneous detachment of the immobilized binding elements from the surface.
  • the degradation causes a reduced sensor response pattern upon detecting the target.
  • the degradation is proportional to the total number of bind/release cycles performed on the sensor surface.
  • the degradation is substantially independent of the concentration of the target in the samples.
  • the system comprises a target-concentration detector to detect a concentration of the target molecules.
  • the accuracy for determination of the target concentration in a sample may be improved.
  • the accuracy may be improved by counting the number of events, such as binding events, washing events, elution events and regeneration events as counted from the beginning of the usage of the sensor surface, followed by comparing the number of the events to the degradation events of the sensor.
  • “accuracy” refers to herein as proximity of concentration of the target in a sample measured by the system compared to the actual concentration measured by a reference instrument or as prepared by the dilution of a known concentration.
  • a number of binding event, elution event, or combinations of both for the reversible operation may be in a range from 2 to 1,000 times. In some embodiments, a number of binding event, elution event, or both of the reversible operations are in a range from 2 to 1,000,000.
  • a thrombin specific binding element sequence GGTTGGTGTGGTTGG (SEQ. ID. NO. 1) and a control binding element sequence GGTGGTGGTTGTGGT (SEQ. ID. NO. 2) were extended with 20 polyT nucleotides and were used for the experiments. Binding elements were additionally functionalized with biotin at their 5′ end.
  • the thrombin specific binding element was immobilized on streptavidin-functionalized (SA) chips (BR-1000-32, GE Healthcare). Chips were first conditioned with three consecutive injections of 1 M NaCl/50 mM NaOH for 1 min.
  • the thrombin specific binding elements were immobilized on the SA chip by loading the binding element solution individually through each channel at a flow rate of 10 ⁇ l/min for 1 minute followed by washing the chip with a HEPES buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA and 0.005% (v/v) Surfactant P20) for 7.5 minutes.
  • the control binding element comprises oligonucleotide comprised of a randomized sequence of similar length and nucleic acid base content and was applied at a similar loading density as the binding element to the reference channel to compensate for non-specific binding.
  • the binding capability of the thrombin specific binding elements upon 365 binding/release cycles were carried out with thrombin concentrations of 0.5, 1, 2, 4, and 8 nM, as shown in FIG. 4 .
  • the flow rate was set at 20 ⁇ l/min.
  • the thrombin binding buffer contained 0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA and 0.005% (v/v) Surfactant P20 (BR-1001-88, GE Healthcare) containing 5 mM MgCl 2 (running buffer).
  • the regeneration (injection time 0.5 min) after each cycle was carried out with a mixture of 50 mM NaOH/1 M NaCl.
  • FIG. 4 depicts K d values with the number of the bind/release cycle of reversible performance of the immobilized binding element.
  • FIG. 6 shows the K d is consistent throughout the 365 cycles of regeneration. Immobilized binding element demonstrates in FIGS. 5 and 6 , high stability of the binding constant K d during their 365 bind/release cycles of reversible operation.
  • the gradual loss of binding signal in FIG. 4 was likely due to the slow but not insignificant dissociation rate of biotin-streptavidin of the biotinylated binding element from the streptavidin surface.
  • the reduction in binding capacity of the aptamer-functionalized streptavidin chip was analyzed from the standpoint of the streptavidin-biotin linker chemistry. While the streptavidin-biotin interaction is uncommonly strong with K d ⁇ 10 ⁇ 14 M, its finite dissociation rate was noticeable over experiments with 365 cycles ( FIG. 4 ).
  • the results of a global fit to the change in maximal signal prior to the thrombin dissociation phase for the five thrombin concentrations used in our studies are presented in FIG. 7 .
  • the experimentally determined 1.6 ⁇ 10 ⁇ 6 s ⁇ 1 correction factor was further applied to the original plasmon resonance signal shown in FIG. 4 .
  • This correction ( FIG. 8 ) successfully normalized the signal for the duration of the 365 regeneration cycles.
  • Covalent attachment of aptamers to detection surfaces or the thermo-precipitatable polymer improves the reusability.
  • FIG. 8 illustrates accurate detection of thrombin after sensor signal correction over 365 bind/release cycles of reversible operation of immobilized thrombin aptamer bioreceptors.
  • a thrombin specific binding element sequence and a control binding element sequence were same as in Example 1, also extended with 20 polyT nucleotides and additionally functionalized with biotin at their 5′ end.
  • the thrombin specific binding element was immobilized on streptavidin-functionalized (SA) chips (BR-1000-32, GE Healthcare) same as in Example 1.
  • FIG. 9 shows results of binding of thrombin followed by regeneration of the thrombin specific binding element with deionized water.

Abstract

A method of recovering a target from a sample is provided. The method of recovering the target follows different steps. The steps include providing a binding element, wherein the binding elements are immobilized on a solid support, adding the sample comprising the target to the binding element to form a binding element-target complex; washing the binding element-target complex; and eluting the target from the binding element-target complex. The system for reversible detection of target in a range from 2 to 1,000,000 bind/release cycles is also provided.

Description

    STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH & DEVELOPMENT
  • This invention was made with Government support under contract number HSHQDC-10-C-00206 awarded by the Department of Homeland Security. The Government has certain rights in the invention.
  • SEQUENCE LISTING
  • The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Sep. 30, 2013, is named 272208-1_SL.txt and is 730 bytes in size.
  • FIELD OF INVENTION
  • The invention generally relates to methods and systems for target detection using nucleic acid based binding elements capable of undergoing repeated regeneration cycles.
  • BACKGROUND
  • Binding elements including affinity ligands, such as antibodies are valued for their high selectivity and affinity, however, the stability of the molecules for their size and complex structure is an issue. Engineered protein binders have proved to be successful as affinity ligands for their small size, stability, and ease of synthesis in microbial production systems, however these binders might be unsuitable for therapeutic applications because of their potential immunogenicity. Additionally the protein binders are expensive, and are not suitable for repeated use. Alternate binding elements based on nucleic acids, such as DNA or RNA have been developed for target specific binding.
  • Binding elements that offer higher stability, selectivity and specificity towards the target and provide solutions to fit both the single-use and multiple-use paradigms are highly desirable. Moreover, reusability of the binding elements for detection of multiple targets is a current need, which may reduce the expense of the detection process.
  • BRIEF DESCRIPTION
  • In one embodiment, a method of recovering a target from a sample, comprises providing a substrate coupled binding element, wherein the binding element is immobilized on a solid support; adding the sample comprising the target to the substrate coupled binding element to form a substrate coupled binding element-target complex; washing the substrate coupled binding element-target complex; and eluting the target from the substrate coupled binding element-target complex.
  • In another embodiment, a method for reversible detection of a target, comprises immobilizing one or more binding elements on a sensor surface, contacting a sample comprising an unknown concentration of the target to the binding elements on the sensor surface to form a binding element-target complex in a target binding event; detecting the target-binding event with a detector to generate a detection signal; eluting the target from the binding element-target complex in an elution event; applying a regeneration solution to complete the removal of the target bound to the binding element in a regeneration event; determining a number of the target-binding event, the elution event, regeneration event or combinations thereof; and applying a correction to the detection signal based on the number of the binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target over at least 100 bind/release cycles.
  • In another embodiment, a method for reversible detection of a target and quantitation of a target concentration in a sample, comprises immobilizing one or more binding elements on a sensor surface, contacting a sample comprising the target to the binding elements to form a binding element-target complex in a target binding event; detecting the target-binding event with a detector to generate a detection signal; eluting the target from the binding element-target complex in an elution event; applying a regeneration solution to regenerate the binding element in a regeneration event; determining a number of the target binding event, the elution event, the regeneration event or combinations thereof; and applying a correction to the detection signal based on the number of the target binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target and quantitation of the target concentration over at least 100 bind/release cycles.
  • In one embodiment of a system for reversible detection of a target, the system comprises a sample holder comprising one or more binding elements immobilized on a surface, wherein the surface is configured to load a sample comprising the target to complete a binding event forming a binding element-target complex; an inlet to supply at least a first solution to wash the binding element-target complex; an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event; a detector to generate a detection signal in proportion to the concentration of the target in the sample; and a processor for calibrating performance of the system for reversible operation of the immobilized binding elements.
  • In another embodiment, a system for reversible detection of a target, comprises a sample holder comprising one or more binding elements immobilized on a surface of the sample holder, wherein the surface is configured to load a sample comprising the target to form a binding element-target complex to complete a binding event; an inlet to supply at least a first solution to wash the binding element-target complex to complete a washing event; an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event; a target-concentration detector to generate a detection signal in proportion to a concentration of the target in the sample; a counter for counting the binding event, washing event, elution event or combinations thereof; and a processor for calibrating a performance of the system based on a number of prior performed bind-release cycles for accurate reversible operation of the immobilized binding elements.
  • DRAWINGS
  • These and other features, aspects, and advantages of the present invention will become better understood when the following detailed description is read with reference to the accompanying drawings in which like characters represent like parts throughout the drawings, wherein:
  • FIG. 1 is a flow chart showing a method for target detection using binding elements in accordance with one embodiment of the invention.
  • FIG. 2 is a schematic diagram showing a system for target detection using binding elements in accordance with one embodiment of the invention.
  • FIG. 3 is a schematic representation of a process flow diagram using the system, wherein the system performs multiple cycles of the detection in accordance with one embodiment of the invention.
  • FIG. 4 is a graph showing binding of thrombin followed by regeneration of the thrombin specific binding element in accordance with one embodiment of the invention.
  • FIG. 5 is a graph showing high stability of the binding constant Kd for Thrombin during 365 bind/release cycles of reversible operation as a function of performed bind/release cycles.
  • FIG. 6 is a histogram showing the binding constant Kd for thrombin during 365 bind/release cycles.
  • FIG. 7 is a series of graphs showing detection of thrombin using varying concentrations over 365 bind/release cycles for reversible operation using immobilized thrombin specific binding element.
  • FIG. 8 is a graph showing detection of thrombin using corrected sensor response.
  • FIG. 9 is a graph showing binding of thrombin followed by regeneration of the thrombin specific binding element using deionized water in accordance with one embodiment of the invention.
  • DETAILED DESCRIPTION
  • To more clearly and concisely describe and point out the subject matter of the claimed invention, the following definitions are provided for specific terms, which are used in the following description and the appended claims. Throughout the specification, exemplification of specific terms should be considered as non-limiting examples.
  • The singular forms “a”, “an” and “the” include plural referents unless the context clearly dictates otherwise. Approximating language, as used herein throughout the specification and claims, may be applied to modify any quantitative representation that could permissibly vary without resulting in a change in the basic function to which it is related. Accordingly, a value modified by a term such as “about” is not to be limited to the precise value specified. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value. Similarly, “free” may be used in combination with a term, and may include an insubstantial number, or trace amounts while still being considered free of the modified term. Where necessary, ranges have been supplied, and those ranges are inclusive of all sub-ranges there between.
  • As used herein, the term “bind/release cycle” refers to the sequence of events that include introducing a sample comprising a target to a surface comprising binding elements immobilized onto the surface, such as a sensor surface, binding the target to the binding element to form a binding element target complex, applying a washing solution to the a binding element target complex, applying an elution and/or applying a regeneration solution to the binding element target complex to elute the target and regenerate the binding element for subsequent use. The term “bind/release cycle” or “cycles: are interchangeably used hereinafter.
  • As used herein the term “nucleotide” or “nucleotide base” refers to a nucleoside phosphate. The term includes, but is not limited to, a natural nucleotide, a synthetic nucleotide, a modified nucleotide, or a surrogate replacement moiety (e.g., inosine). The nucleoside phosphate may be a nucleoside monophosphate, a nucleoside diphosphate or a nucleoside triphosphate. The sugar moiety in the nucleoside phosphate may be a pentose sugar, such as ribose, and the phosphate esterification site may correspond to the hydroxyl group attached to the C-5 position of the pentose sugar of the nucleoside. A nucleotide may be, but is not limited to, a deoxyribonucleotide triphosphate (dNTP) or a ribonucleotide triphosphate (NTP). The nucleotides may be represented using alphabetical letters, for example, A denotes adenosine (e.g., a nucleotide containing the nucleobase, adenine), C denotes cytosine, G denotes guano sine, and T denotes thymidine.
  • As used herein, the term “oligonucleotide” refers to oligomers of nucleotides or derivatives thereof. The term “nucleic acid” as used herein refers to polymers of nucleotides or derivatives thereof. The term “sequence” as used herein refers to a nucleotide sequence of an oligonucleotide or a nucleic acid. Throughout the specification, whenever an oligonucleotide/nucleic acid is represented by a sequence of letters, the nucleotides are in 5′→3′ order from left to right. The oligonucleotides/nucleic acids may be a DNA, an RNA, or their analogues (e.g., uracil, inosine analogue). The oligonucleotides or nucleic acids may also include modified bases and/or backbones (e.g., modified phosphate linkage such as thiophosphate or modified sugar moiety, such as locked nucleic acid). Non-limiting examples of synthetic backbones that confer stability and/or other advantages to the nucleic acids may include phosphorothioate linkages, peptide nucleic acid, locked nucleic acid, xylose nucleic acid, or analogues thereof. The oligonucleotide refers to a linear oligonucleotide that may include 5 to 1000 nucleotides. Both the upper and lower limits of the length of the oligonucleotide are empirically determined. The lower limit on oligonucleotide length is the minimum length that is required to form a transient complex upon binding with the target molecule under desired reaction conditions. Very short oligonucleotides (usually less than 3-4 nucleotides long) do not form thermodynamically stable complex with target molecule under such conditions. The upper limit of oligonucleotide length is the maximum length that the linear oligonucleotide sequence can be accurately amplified (usually around 1000-5000 nucleotides).
  • The oligonucleotides may also be interchangeably referred to herein as “oligomers” or “short oligomers”. The oligonucleotide may be an RNA sequence, a DNA sequence, or a chimeric sequence comprising different bases. The oligonucleotide may contain natural, synthetic, or modified nucleotides. Generally, suitable oligonucleotide lengths are in the range of 4-5000 nucleotides, more specifically, between 4-100 nucleotides long.
  • In some embodiments, the oligonucleotide refers to a linear oligonucleotide that may include 5 to 1000 nucleotides. The upper limit of oligonucleotide length may be the maximum length that the linear oligonucleotide sequence be accurately amplified (usually around 1000-5000 nucleotides). Suitable oligonucleotide lengths may be in the range of 4-5000 nucleotides, or between 4-100 nucleotides long.
  • As used herein, the term “target molecule” refers to a molecule that is of interest to determine its concentration in the analyzed sample. The target molecule may be an organic molecule, an inorganic molecule, a biological molecule, a synthetic molecule or combinations thereof. In one or more embodiments, the target molecule may be a protein, a post-translationally modified protein, a peptide, a carbohydrate, a drug, a carrier, a small molecule, an adapter, an epitope or combinations thereof. The target molecule may comprise a single entity or a multiple entity. In one example, a cell-surface protein is a single entity, which has only one binding motif and that can be a single entity target.
  • As noted, the target molecule may comprise a multiple entity, such as, one or more cell-surface proteins have epitopes that are associated with multiple single entities. For example, the target may be a specific combination of epitopes, such as, a multi-subunit protein complex or a section of a cell surface comprising the multi-subunit protein. In another example, when the target molecule comprises a multiple entity, the non-limiting examples of a multiple entity include surface of a cell, surface of a virus, surface of a tissue, at least two outer regions of a folded polymer molecule, at least two outer regions of a folded biopolymer molecule, a surface of an inorganic amorphous material, and a surface of an inorganic crystalline material. In these examples the binding element for such a target has a single binding motif or more than one binding motif.
  • The term “binding element” refers to herein as an oligonucleotide-based component that efficiently binds to a target molecule through one or more binding sites through different types of interactions, including but are not limited to, hydrophobic, Van der Waals interactions and hydrogen bonding. The binding element may include an aptamer, such as deoxyribonucleic acid (DNA) aptamer, ribonucleic acid (RNA) aptamer or peptide nucleic acid (PNA) aptamer.
  • One or more embodiments of the invention are directed to methods for detection and recovery of a target from a sample using binding elements. In one embodiment, a method of recovering a target from a sample, comprises providing a substrate coupled binding element, wherein the binding element is immobilized on a solid support; adding the sample comprising the target to the substrate coupled binding element to form a substrate coupled binding element-target complex; washing the substrate coupled binding element-target complex; and eluting the target from the substrate coupled binding element-target complex.
  • The target molecule and the binding element are in contact, which enable the binding elements to bind to the target molecules and form a substrate coupled binding element-target complex. In some embodiments, the target molecule and the binding element are mixed thoroughly to form a binding element-target complex in a first solution. In one or more embodiments, the target molecules and the binding elements are mixed in the first solution using different mixing techniques, such as by pipetting up and down, vortexing, mild shaking, waving or stirring. In one or more embodiments the target molecules and the binding element are incubated at a specific temperature without any mixing or agitation.
  • As noted, the method comprises addition of the sample to the binding element, wherein the target and the binding element may be in contact to each other, which results in formation of a substrate coupled binding element-target complex. In some embodiments, the plurality of binding elements has affinity for the target molecules. As noted, the method comprises forming a binding element-target complex. The term “binding element-target complex” refers to a complex wherein a binding element is bound to a target molecule. In some embodiments, the addition of substrate coupled binding element to the target forms a substrate coupled binding element-target complex. The term “binding element-target complex” or “complex” is interchangeably used hereinafter. In these embodiments, the first solution comprises the substrate coupled binding element-target complex, excess unbound target, other molecules and impurities. As mentioned, the “other molecules”, these molecules may have structural similarity with the target.
  • The affinity of the binding element for the target molecules may enhance the binding efficiency of the binding element to the target. In some embodiments, the binding elements are bound to the target molecules by ionic interaction, H-bonding, Vander Waal's forces or combinations thereof. In some embodiments, the binding element target complex is stabilized by adding a reaction buffer to the mixture. In one embodiment, the binding element-target complex comprises the binding element and the target in 1:1 ratio.
  • In one or more embodiments, as noted, the binding element is immobilized on a solid support. In one or more embodiments, the method comprises providing a binding element immobilized on a solid support, adding a sample comprising a target to the substrate coupled binding element to form a binding element-target complex that is immobilized to the solid support. The binding element-target complex is washed followed by elution of the target from the binding element-target complex. In one or more embodiments of the method, the binding element immobilized on a solid support is recycled for multiple times.
  • The binding element immobilized on a solid support may be recycled for 2 to 100,000 times, in some other embodiments, the binding element immobilized on a solid support is recycled for 2 to 100 times. The structural integrity of the substrate coupled binding element remains intact, which ensures binding efficiency of the binding element to the target for multiple cycles. As noted earlier, the term, “bind/release cycle” or “cycles” are used herein interchangeably to describe a complete event that is combination of the binding event, washing event, the elution event and regeneration event. In case of multiple cycles, for example, a target binds to the binding element and followed by elution of the target from the binding element leaving the binding element free for next target to bind, the complete process refers to a complete cycle. Depending on efficiency of the binding element, the number of cycles can be repeated. As the binding elements are coupled with a substrate, the substrate may also maintain the structural integrity for multiple uses.
  • The solid support may be a surface of any solid material or a substance. The non-limiting examples of solid support may include a glass slide, a sensor chip, a petri-plate, a petri-dish, a test tube, a beaker, a container, a solid matrix, a hydrogel, a membrane. A solid material with an exposed surface may be used as a solid support, for example, a metal sheet, a glass slide or a plastic plate. The solid support may be a component of a system, wherein a surface of the component may function as a solid support for holding the substrate coupled binding elements.
  • As noted, in the embodiments, wherein the binding element is immobilized on a solid support, the binding element-target complex is also immobilized on the solid support. In some embodiments, the substrate coupled binding element has sufficient affinity and selectivity for the target, such that the substrate coupled binding element select the appropriate molecule as a target and binds the target to form a binding element-target complex.
  • In one or more embodiments, the binding element-target complex is washed with a washing solution. As noted, the “washing solution” may refer to a solution that provides a washing condition which does not destabilize the binding element-target complex. The washing solution may be selected depending on the binding element or the target, and the stability of the binding element-target complex. The washing may be performed when the complex is bound to a solid support. The washing may remove un-bound or non-specifically bound molecules present in the sample, or any impurities present in the solution comprising the binding element-target complex. In one or more embodiments, the washing comprises repeated washing cycles. Repeated washings may ensure presence of only specifically bound target to the binding element. In these embodiments, washing solution is used for washing the complex attached to the solid support. The post-wash liquid may be removed to eliminate any un-bound target, non-specifically bound other molecules or any impurities.
  • As noted, in one or more embodiments, the method further comprises dissociating and eluting the target from the complex using an “elution solution”. As noted, an ‘elution solution’ may refer to a solution that elutes the target from the binding element-target complex using various methods. In some embodiments, the elution is achieved by one or more of the methods selected from: re-constituting the substrate coupled binding element-target complex in a solution to dissociate the target, washing the complex with either a buffer with a high ionic strength or using mild conditions, inducing a conformational change to the binding element or binding element-target complex.
  • As noted, the elution of the target is achieved by re-constituting the substrate coupled binding element-target complex in a solution to dissociate the target, wherein one or more elution solutions may be used. In some embodiments, the elution solution may regenerate the binding element for next or subsequent binding event. As noted, in one or more embodiments, the method further comprises dissociating the binding element-target complex to form the substrate coupled binding element and the target under mild conditions using an elution solution.
  • As noted, the binding element-target complex may be dissociated under mild conditions, the term “mild condition” refers to herein as a condition which causes minimum structural change of the binding element so that it can release the target, however the condition ensures minimum or no structural or functional change to the target. In some embodiments, the mild conditions allow recovery of the target in an un-denatured form with minimal aggregation or unfolding. In some embodiments, the mild condition causes a conformational change to the binding element and retains the intact structure and function of the target.
  • As noted, in some embodiments, the mild condition causes a conformational change to the binding element; one or more solutions may be added to the binding elements to regenerate the actual structure of the binding element. These solutions are referred to herein, as a “regeneration solution”. The ‘regeneration solution’ may be used for regenerating the binding element under mild conditions. In some embodiments, the regeneration solution regenerates the binding elements by recovering the actual structure and function. In some embodiments, the regeneration solution also functions as elution solution, as the solution also elutes the target. In these embodiments, the regeneration solution is used for washing the complex and elutes the target. In these embodiments, the solution regenerates the binding element during elution of target or after elution of the target. In some embodiments, the requirement of elution and regeneration is different and that depends on the selection of binding element or target. In these embodiments, the regeneration solution only recovers the structure or function of the binding element but not elute the target. In some embodiments, the regeneration solution which helps to regain the actual structure of the binding element after conformational change to the binding element, may include, but are not limited to, a buffer with a high ionic strength, a diluted base, a salt solution or deionized water, guanidinium hydrochloride, sodium hydroxide, sodium chloride, and mixtures of sodium hydroxide and sodium chloride.
  • In some embodiments, when the mild condition causes minimum structural change to the target, the change is a reversible conformational change. In these embodiments, the target regains its original structure after recovery. For example, in the case of a nucleic acid based binding element, the conditions are selected that favor conformational change to the nucleic acid binding element however, maintains the tertiary structure and function of the target. As noted, the mild conditions allow for reuse of the binding element. In these embodiments, the regeneration solution is used to regenerate the binding element for multiple uses. In case of binding element used for detection or sensor applications, easy removal of analyte target allows reuse of the sensor, preferably many times over with minimal loss of binding capacity or destruction of the binding element. In these embodiments, minimal loss of binding capacity may also be recovered using one or more of the regeneration solutions.
  • One or more examples of the mild condition may include, use of deionized water, weak bases, salts or chelators. The deionized water may un-shield the charge on the phosphate backbone of nucleic acids (such as DNA) and hindering secondary structure formation. In some examples, dilute base, such as 0.1-50 mM may also be used to reduce secondary structure of the nucleic acids. The use of NaCl with a concentration of 1M or greater may also be used for effectively reducing ionic interactions. In some examples, the structure of the binding element is stabilized by metal ions, wherein the binding element may be destabilized using a metal chelator. In one embodiment, a liquid with low ionic strength, such as deionized water, is used to dissociate the target molecule. A liquid with low ionic strength is desired as the liquid helps in efficient downstream purification or detection; for example buffer exchange.
  • In some embodiments, the target in the sample may be concentrated by adding the sample to the binding element bound to the solid surface, purified from non-target molecules by using a washing solution and eluted from the binding element bound to the solid surface by water, low ionic strength solution or other mild conditions. The target may further be detected downstream of the binding element bound to the solid surface. Conditions for elution of the target from the first binding element may retain the binding ability of the target to the downstream binding element. The “downstream” is defined herein, as the second binding element positioned after the first binding element in accordance to the sample flow path. Detection means may include either the same or different binding element bound to a solid surface detection device. In some embodiments, different sets of binding elements are used for detection which may increase the selectivity for the target. Further, water or low ionic strength elution conditions are used for eluting the target from the binding element following pre-concentration step.
  • The elution may cause structural change to the binding element to release the target. The elution method ensures a minimum or no structural or functional change to the target. In some embodiments, a conformational change is induced to the binding element to release the target, wherein the target retains the intact structure and function. In some embodiments, a minimum structural change may result in the target, wherein the change is a reversible conformational change. In these embodiments, the target regains its original structure after recovery and re-constitution. For example, a target, such as a protein has a minimum conformational change during recovery with water or a buffer with low ionic strength. The protein target regains its original structure and function, when the target is reconstituted in a buffer with desired ionic strength.
  • In one or more embodiments, the binding element is coupled to a substrate, wherein the substrate comprises a polymer, a protein, a peptide, a carbohydrate, a small molecule or combinations thereof. In some embodiments, the substrate comprises a stimuli-responsive polymer. The stimuli-responsive polymer may comprise a thermo-responsive polymer, a pH responsive polymer, a pressure responsive polymer, a humidity responsive polymer, an ionic strength responsive polymer, a light responsive polymer or combinations thereof. A nonlimiting example of a stimuli-responsive polymer is a hydrogel such as dextran.
  • In some examples, the substrate is a tag or a linker, which includes, but are not limited to, a streptavidin coated bead, a histidine tag, a glutathione S-transferase (GST) tag, a maltose binding protein (MBP) tag, a fusion comprising an antibody Fc region, a bifunctional reagent linker, or a linker comprising biotin. In one embodiment, the substrate comprises a polymer. In some embodiments, the substrate comprises a stimuli responsive polymer. For example, the substrate is a thermo responsive polymer, a pH responsive polymer, a light responsive polymer or combinations thereof. In some embodiments, the substrate comprises dual responsive polymer, such as a thermo responsive polymer, which is also responsive to pH.
  • In some examples, the substrate is a sensor surface. The sensor surface may include, but are not limited to, glass, quartz, polymer, gold, platinum, nanoparticle surface, nanotube surface, or nanorod surface. The sensor is employed to detect the binding events, elution events or combinations thereof and ensure reversible binding/release cycles.
  • In one embodiment, the method is employed for reversible detection of a target. In these embodiments, the method comprises immobilizing one or more binding elements on a sensor surface, followed by contacting a sample comprising the target to the binding elements on the sensor surface. The contact between binding elements and target ensures forming a binding element-target complex in a target binding event. The sensor may comprise a detector for detecting the target-binding event to generate a detection signal. The detector may provide the information about the concentration of the target in the sample. The target is eluted from the binding element-target complex in an elution event; and the sensor determines a number of the target-binding event, the elution event or combinations thereof as counted from the beginning of the usage of the sensor surface followed by applying a correction to the detection signal based on the number of the binding event, the elution event or combinations thereof during the reversible detection of the target to improve accuracy of quantitation of target concentration over at least 100 bind/release cycles.
  • In another embodiment, a method for reversible detection of a target and quantitation of a target concentration in a sample is provided. The method comprises immobilizing one or more binding elements on a sensor surface and contacting a sample comprising the target to the binding elements to form a binding element-target complex in a target binding event. The target binding event is followed by detection of the target-binding event with a detector to generate a detection signal in proportion to the concentration of the target in the sample and eluting the target from the binding element-target complex in an elution event. After eluting the target, a regeneration solution is further applied to complete the removal of the target bound to the binding element and to regenerate the binding element in a regeneration event, determining a number of the target binding event, the elution event, the regeneration event or combinations thereof as counted from the beginning of the usage of the sensor surface. After these, a correction is applied to the detection signal based on the number of the target binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target to accurately quantify the target concentration over at least 100 bind/release cycles.
  • The target molecule may be an organic molecule, an inorganic molecule, a biological molecule, a synthetic molecule or combinations thereof. In one or more embodiments, the target molecule may be a protein, a post-translationally modified protein, a peptide, a carbohydrate, a drug, a carrier, a small molecule, an adapter, a virus, a cell or combinations thereof. The term “carrier” refers to a compound that may attach to one or more drug, protein, peptide, carbohydrate, lipid, genetic material or small molecule for targeted delivery and controlled release. The carrier may include a synthetic compound or a natural compound isolated from different sources. The carrier may be a nanoparticle. In one embodiment, the target molecule is a protein or peptide. For example, the target molecule is thrombin. The target molecules may be present in a solution, an extract or a formulation, which may be present in a sample at a concentration, ranged between 1 pM and 1 mM.
  • In one or more embodiments, the binding elements function as affinity ligands and are selected for high affinity binding to molecular targets, wherein the oligomers are selected for synthesizing binding elements. In some embodiments, the binding element is an oligonucleotide sequence, a DNA sequence, an RNA sequence, a PNA sequence, a peptide sequence or combinations thereof. The binding element may comprise a protein binding sequence or one or more tandem repeat sequences or one or more protein binding sequences. In some embodiments, the binding elements are ranging between 15-60 nucleotides in length. The binding element may include substitutions on the base portion of DNA to enhance hydrophobic interactions with target molecules. In an exemplary embodiment, the binding element comprises a DNA aptamer, which is attractive for its pH and thermal stability, small size (˜13 kDa), and high binding efficiency. DNA aptamers may be considered as an efficient affinity binder in the context of downstream processing. The ease of binding element synthesis may be an additional benefit, since it allows synthesizing a less expensive binding element compared to its protein-based counterparts, in addition to reproducibility in synthesis process. A further favorable characteristic of DNA binding element is easy manipulation that disrupts the secondary structure of the binding element which leads to dissociation of the target from the binding element, enabling recovery of the target molecule using mild elution conditions.
  • FIG. 1 is a flow chart illustrating an exemplary embodiment of a method 30 for selecting a specific target 34 using binding element 32 immobilized on a solid support. In an alternative embodiment, some of the steps may be performed simultaneously or in different order. In some embodiments, one or more steps may be added to the flow chart. Nonlimiting examples of these steps include detecting the concentration of the target bound to the binding element immobilized on a solid support and counting the number of the target binding events, the number of elution events as counted from the beginning of the usage of the solid support. The flow chart of FIG. 1 includes the step of adding a sample comprising a target 34 to the binding element 32 to form a binding element-target complex 36. The binding element-target complex 36 is washed to recover purified binding element-target complex 40, wherein the impurities 38 are removed. The washing is followed by elution of the target 42 from the binding element 32 immobilized on a solid support. In one or more embodiments, the solid support immobilized binding element is couples to a substrate or a linker. In one or more embodiments of the method, the binding element 32 immobilized on a solid support is recycled for repeated use.
  • An embodiment of a system for reversible detection of a target is provided herein in FIG. 2, wherein the system comprises a sample holder 50 with a fluidic path comprising a sensor chip 52 with one or more binding elements immobilized on a surface of the sensor chip 54. If a sample comprising a target is added to the surface of the sensor chip 54, a target-binding element complex formed and bound to the sensor chip 56. The system further comprises a target concentration detector 58 to detect the sensor signal level upon target binding events. The system further comprises one or more inlets 60 to supply at least one washing or elution solution and samples comprising an unknown concentration of the target.
  • During operation, a sample comprising the unknown concentration of the target is applied to the sensor via system inlet 60. A washing solution and an eluting solution are also supplied through the system inlet 60 for washing or elution, respectively. After applying the washing or elution solution, a regeneration solution is applied to regenerate the binding element. The system further comprises an outlet 62 for removing post wash liquid. The system also comprises a counter 64 and a processor 66. The system allows binding of the target to the surface-immobilized binding elements followed by release of the specifically bound target, wherein the binding/release cycle may be repeated for multiple times. The lines with arrows in FIG. 2 connecting the individual components illustrate the electrical or fluidic relations between the different components of the system.
  • In another embodiment, the system comprises at least two sensing regions with immobilized binding elements, where each region contains a different type of the immobilized binding elements. The sample with unknown concentration of the target is sequentially or in parallel introduced to each of the sensing regions. The sequential or parallel operation with at least two sensing regions provides the improved selectivity of determination of target binding.
  • The surface is configured to load a sample comprising the target to complete a binding event forming a binding element-target complex. As noted, the term “configured to” refers to structure or configuration of the surface, wherein one or more binding elements are attached to the surface. The term “immobilized” refers to herein as the binding elements are attached to the surface, such that the binding elements are tightly bound to the surface. The binding elements may have minimum possibility to detach from the surface during system operation. The attachment of the binding elements to the surface is achieved by using known techniques with nonlimiting examples that include a covalent attachment using thiol, amine, or hydroxysuccinimidyl functionalization and an attachment using streptavidin-biotin immobilization chemistry. In some embodiments, the binding elements are immobilized on the surface through one or more substrates. The substrate may include a polymer, a metal, a cellulose, a glass, a peptide, a carbohydrate or combinations thereof.
  • The embodiments of the system further comprise an inlet 60 to supply a first solution to wash the binding element-target complex. As noted, the system also comprises another inlet to supply a second solution to elute the target from the binding element-target complex to complete an elution event. In some embodiments, the system comprises a single inlet 60 that supplies both the first solution and the second solution, depending on requirement. In these embodiments, the system comprises a valve near the inlet, and the inlet may be connected to two different reservoirs, one contains first solution and the other contains second solution. The system also comprises an inlet that supplies a regeneration solution (or regeneration solution) that is applied to regenerate the binding element. A regeneration solution changes the conformation of the binding element that allows releasing the bound target.
  • The system may also comprise a controller, that controls the valve and release the required solution to the system during the binding or release cycle. The system may further comprise one or more chambers configured to hold one or more solutions, such as a first solution or a second solution. The system may further comprise a collection chamber for collecting the target after elution. As noted, one or more solutions may be used, for example when the process requires washing under different conditions to achieve a fast washing or second washing. The system may further comprise additional chambers configured to hold additional solutions. The system may further comprise specific environmental controllers, such as a heating element or a UV light source.
  • As noted, the system further comprises a target-concentration detector 58, wherein the detector 58 detects complete binding event. A target-concentration detector 58 measures the concentration of the target that may be bound to the immobilized binding element. Nonlimiting examples of such a target-concentration detector include optical detector, electronic detector, electrochemical detector, gravimetric detector, mechanical detector, plasmonic detector, impedance detector, acoustic-wave detector, or any other detector known in the art.
  • As noted, the system further comprises a counter 64 for detecting, counting and logging the number of the binding events, the elution event or combinations thereof as counted from the beginning of the usage of the sensor surface for reversible operation of the binding element. A nonlimiting example of such a counter 64 is an electronic circuit that counts events of operating the target-concentration detector and performing washing steps.
  • In one or more embodiments, a washing event and an elution event are different. A washing event is wash with a buffer that maintains binding of target to the binding element, wherein the wash buffer may be similar buffer that used to select the binding element. Washing is included to remove non-targets that are either physically entrapped or non-specifically bound non-targets. In these embodiments, the solutions are used to dissociate the target from the binding element. The solutions generally used for elution may be different from the solutions used to select the binding element for the target, such as, water, solution with low ionic strength, solution of dilute base (0.1-50 mM), or solution comprising chelators, chaotrope or salt used for washing solution.
  • The embodiments of the system also comprise a processor 66 for calibrating performance of the system for reversible operation of the immobilized binding elements. The processor 66 may provide a dissociation constant of the binding elements immobilized on the surface after each elution event. The processor 66 may further analyze a sensor response value for further correction. The processor may also store the sensor calibrations based on the tested target concentrations and the number of bind/release cycles for the sensor. In some embodiments, the system comprises a counter 64 which is synchronized with the processor 66 and compensates any loss of binding capacity. In some embodiments, the counter 64 together with the processor 66 allows for compensation of any loss of binding capacity of the sensor chip with the immobilized binding element and preserves the accuracy of the determinations of the bound target upon multiple operation cycles of the sensor. The compensation of the loss of binding capacity of the sensor chip with the immobilized binding element may be performed by the prior determination of the loss of binding capacity of the sensor chip with the immobilized binding element during the calibration routines, determination of the mathematical functional relationship between the loss of binding capacity of the sensor chip with the immobilized binding element and the number of the operation cycle and storing the mathematical functional relationship in the memory of the processor.
  • FIG. 3 shows an exemplary embodiment of a process flow diagram using the system, wherein the system performs multiple cycles of the detection. In one embodiment, a system for reversible detection of a target comprises a sample holder comprising one or more binding elements immobilized on a surface 70, as shown in FIG. 3. In some embodiments, the binding elements are activated using a buffer or water, forming activated binding elements 72. The surface is configured to load a sample comprising the target 74 to complete a binding event. The binding event results in forming a binding element-target complex 76. The system further comprises an inlet to supply at least a first solution to wash the binding element-target complex and an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event. Using one or more solution, the binding elements are deactivated, 78. The deactivated binding elements release the target 74. The system may further comprise a target-concentration detector 58 to measure the concentration of the target that may be bound to the immobilized binding element. A counter may be present in the system for counting the binding event, elution events or combinations thereof as counted from the beginning of the usage of the surface. The system may further comprise a processor for calibrating 80 performance of the system based on the number of prior performed bind/release cycles for an accurate reversible operation of the immobilized binding elements (FIG. 3).
  • In some embodiments, upon reversible operation of the sensor comprising binding elements immobilized on the sensor surface, the sensor surface experience degradation. A non-limiting example of the term “degradation” refers to a spontaneous detachment of the immobilized binding elements from the surface. The degradation causes a reduced sensor response pattern upon detecting the target. In some embodiments, the degradation is proportional to the total number of bind/release cycles performed on the sensor surface. In these embodiments, the degradation is substantially independent of the concentration of the target in the samples. Thus, by knowing the number of performed bind/release cycles, the detector response may be corrected with regard to the degradation of sensor surface. This correction improves the accuracy of detection.
  • As noted, in some embodiments, the system comprises a target-concentration detector to detect a concentration of the target molecules. The accuracy for determination of the target concentration in a sample may be improved. In some embodiments, the accuracy may be improved by counting the number of events, such as binding events, washing events, elution events and regeneration events as counted from the beginning of the usage of the sensor surface, followed by comparing the number of the events to the degradation events of the sensor. As noted, “accuracy”, refers to herein as proximity of concentration of the target in a sample measured by the system compared to the actual concentration measured by a reference instrument or as prepared by the dilution of a known concentration.
  • A number of binding event, elution event, or combinations of both for the reversible operation may be in a range from 2 to 1,000 times. In some embodiments, a number of binding event, elution event, or both of the reversible operations are in a range from 2 to 1,000,000.
  • Example 1 Reversible Operation of Biosensor with Immobilized Binding Elements for 365 Cycles Using 50 mM NaOH/1 M NaCl Solution for Sensor Regeneration
  • A thrombin specific binding element sequence GGTTGGTGTGGTTGG (SEQ. ID. NO. 1) and a control binding element sequence GGTGGTGGTTGTGGT (SEQ. ID. NO. 2) were extended with 20 polyT nucleotides and were used for the experiments. Binding elements were additionally functionalized with biotin at their 5′ end. The thrombin specific binding element was immobilized on streptavidin-functionalized (SA) chips (BR-1000-32, GE Healthcare). Chips were first conditioned with three consecutive injections of 1 M NaCl/50 mM NaOH for 1 min. The thrombin specific binding elements were immobilized on the SA chip by loading the binding element solution individually through each channel at a flow rate of 10 μl/min for 1 minute followed by washing the chip with a HEPES buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA and 0.005% (v/v) Surfactant P20) for 7.5 minutes. The control binding element comprises oligonucleotide comprised of a randomized sequence of similar length and nucleic acid base content and was applied at a similar loading density as the binding element to the reference channel to compensate for non-specific binding.
  • The binding capability of the thrombin specific binding elements upon 365 binding/release cycles were carried out with thrombin concentrations of 0.5, 1, 2, 4, and 8 nM, as shown in FIG. 4. The flow rate was set at 20 μl/min. The thrombin binding buffer contained 0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA and 0.005% (v/v) Surfactant P20 (BR-1001-88, GE Healthcare) containing 5 mM MgCl2 (running buffer). The regeneration (injection time 0.5 min) after each cycle was carried out with a mixture of 50 mM NaOH/1 M NaCl.
  • The data obtained in FIG. 4 was further processed to estimate the binding affinity Kd of the binding element for thrombin. A global fit of binding interactions at five concentrations of thrombin provided a Kd of ˜2.5±0.1 nM, consistent with literature values of 1-10 nM based on different immobilization conditions and detection methods. FIG. 5 depicts Kd values with the number of the bind/release cycle of reversible performance of the immobilized binding element. FIG. 6 shows the Kd is consistent throughout the 365 cycles of regeneration. Immobilized binding element demonstrates in FIGS. 5 and 6, high stability of the binding constant Kd during their 365 bind/release cycles of reversible operation. FIG. 5 illustrates the binding constant Kd as a function of performed bind/release cycles for thrombin, wherein FIG. 6 shows histogram of the binding constant Kd over 365 bind/release cycles, Kd=2.5±0.1 nM (mean±1σ).
  • The gradual loss of binding signal in FIG. 4 was likely due to the slow but not insignificant dissociation rate of biotin-streptavidin of the biotinylated binding element from the streptavidin surface. The reduction in binding capacity of the aptamer-functionalized streptavidin chip was analyzed from the standpoint of the streptavidin-biotin linker chemistry. While the streptavidin-biotin interaction is uncommonly strong with Kd˜10−14 M, its finite dissociation rate was noticeable over experiments with 365 cycles (FIG. 4). The results of a global fit to the change in maximal signal prior to the thrombin dissociation phase for the five thrombin concentrations used in our studies are presented in FIG. 7. This global fit estimated a dissociation rate for biotin from the streptavidin to be (1.6±0.1)×10−6 s−1. The experimentally determined 1.6×10−6 s−1 correction factor was further applied to the original plasmon resonance signal shown in FIG. 4. This correction (FIG. 8) successfully normalized the signal for the duration of the 365 regeneration cycles. Covalent attachment of aptamers to detection surfaces or the thermo-precipitatable polymer improves the reusability. FIG. 8 illustrates accurate detection of thrombin after sensor signal correction over 365 bind/release cycles of reversible operation of immobilized thrombin aptamer bioreceptors.
  • Example 2 Reversible Operation of Biosensor with Immobilized Binding Elements for 100 Cycles Using Deionized Water for Sensor Regeneration
  • A thrombin specific binding element sequence and a control binding element sequence were same as in Example 1, also extended with 20 polyT nucleotides and additionally functionalized with biotin at their 5′ end. The thrombin specific binding element was immobilized on streptavidin-functionalized (SA) chips (BR-1000-32, GE Healthcare) same as in Example 1.
  • A study of 100 cycles of regeneration was conducted using deionized water as regeneration solution. The injection time of 15 min was used for water regeneration Thrombin concentrations were 1 nM, 2.5 nM, 5 nM, 10 nM and 20 nM. The 20 cycles were performed for each of injections. Before each thrombin binding experiment, at each concentration, the bound binding element was regenerated with deionized water. FIG. 9 shows results of binding of thrombin followed by regeneration of the thrombin specific binding element with deionized water.
  • While only certain features of the invention have been illustrated and described herein, many modifications and changes will occur to those skilled in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.

Claims (25)

1. A method of recovering a target from a sample, comprising:
providing a substrate coupled binding element, wherein the binding element is immobilized on a solid support;
adding the sample comprising the target to the substrate coupled binding element to form a substrate coupled binding element-target complex;
washing the substrate coupled binding element-target complex; and
eluting the target from the substrate coupled binding element-target complex.
2. The method of claim 1, wherein the binding element is recovered and recycled.
3. The method of claim 1, wherein the binding element is recycled for 2 to 100,000 times.
4. The method of claim 1, wherein the binding element is recycled for 2 to 100 times.
5. The method of claim 1, wherein the solid support is a sensor surface.
6. The method of claim 1, further comprising determining a concentration of the target in the sample.
7. The method of claim 1, wherein the binding element is further coupled to a substrate comprising a polymer, a protein, a peptide, a carbohydrate, a small molecule or combinations thereof.
8. The method of claim 7, wherein the substrate comprises a polymer.
9. The method of claim 7, wherein the substrate comprises one or more stimuli responsive polymer comprising dextran hydrogel, a thermo responsive polymer.
10. The method of claim 1, wherein the substrate comprises a linker selected from a biotin, streptavidin, NHS ester, thiol or combination thereof.
11. The method of claim 1, wherein the washing is achieved with a buffer or a salt solution.
12. The method of claim 1, wherein the elution is achieved by washing the complex with deionized water, dilute base, salt solution, a buffer with low ionic strength, a chelator or combinations thereof.
13. A method for reversible detection of a target, comprising:
immobilizing one or more binding elements on a sensor surface,
contacting a sample comprising an unknown concentration of the target to the binding elements on the sensor surface to form a binding element-target complex in a target binding event;
detecting the target-binding event with a detector to generate a detection signal;
eluting the target from the binding element-target complex in an elution event;
applying a regeneration solution to complete the removal of the target bound to the binding element in a regeneration event;
determining a number of the target-binding event, the elution event, regeneration event or combinations thereof; and
applying a correction to the detection signal based on the number of the binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target over at least 100 bind/release cycles.
14. A method for reversible detection of a target and quantitation of a target concentration in a sample, comprising:
immobilizing one or more binding elements on a sensor surface,
contacting a sample comprising the target to the binding elements to form a binding element-target complex in a target binding event;
detecting the target-binding event with a detector to generate a detection signal;
eluting the target from the binding element-target complex in an elution event;
applying a regeneration solution to regenerate the binding element in a regeneration event;
determining a number of the target binding event, the elution event, the regeneration event or combinations thereof; and
applying a correction to the detection signal based on the number of the target binding event, the elution event, the regeneration event or combinations thereof during the reversible detection of the target and quantitation of the target concentration over at least 100 bind/release cycles.
15. The method of claim 14, wherein the correction to the detection signal improves detection accuracy of the concentration of the target in the sample.
16. The method of claim 14, wherein a number of the reversible detection is in a range from 2 to 1,000,000.
17. The method of claim 14, wherein a number of the reversible detection comprising binding event, elution event, or combinations thereof is in a range from 2 to 1,000.
18. The method of claim 14, wherein the elution is achieved by washing the sensor with an dilute base, a salt solution, a buffer with low ionic strength, a chelator or combinations thereof.
19. A system for reversible detection of a target, comprising:
a sample holder comprising one or more binding elements immobilized on a surface, wherein the surface is configured to load a sample comprising the target to complete a binding event forming a binding element-target complex;
an inlet to supply at least a first solution to wash the binding element-target complex;
an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event;
a detector to generate a detection signal in proportion to the concentration of the target in the sample; and
a processor for calibrating performance of the system for reversible operation of the immobilized binding elements.
20. The system of claim 19, wherein the processor provides a dissociation constant of the binding elements immobilized on the surface after each elution event.
21. The system of claim 19, wherein a number of binding event, elution event, or combinations thereof of the reversible operation is in a range from 2 to 1,000.
22. The system of claim 19, wherein a number of binding event, elution event, or combinations thereof of the reversible operation is in a range from 2 to 1,000,000.
23. The system of claim 19, further comprising a chamber for collecting the target after elution.
24. The system of claim 19, wherein the binding elements are immobilized on the surface through one or more substrates.
25. A system for reversible detection of a target, comprising:
a sample holder comprising one or more binding elements immobilized on a surface of the sample holder, wherein the surface is configured to load a sample comprising the target to form a binding element-target complex to complete a binding event;
an inlet to supply at least a first solution to wash the binding element-target complex to complete a washing event;
an inlet to supply at least a second solution to elute the target from the binding element-target complex to complete an elution event;
a target-concentration detector to generate a detection signal in proportion to a concentration of the target in the sample;
a counter for counting the binding event, washing event, elution event or combinations thereof; and
a processor for calibrating a performance of the system based on a number of prior performed bind-release cycles for accurate reversible operation of the immobilized binding elements.
US14/043,895 2013-10-02 2013-10-02 Methods and systems for detection of target and applications thereof Abandoned US20150093839A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/043,895 US20150093839A1 (en) 2013-10-02 2013-10-02 Methods and systems for detection of target and applications thereof
US15/465,970 US10989709B2 (en) 2013-10-02 2017-03-22 Methods and systems for detection of target and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/043,895 US20150093839A1 (en) 2013-10-02 2013-10-02 Methods and systems for detection of target and applications thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/465,970 Division US10989709B2 (en) 2013-10-02 2017-03-22 Methods and systems for detection of target and applications thereof

Publications (1)

Publication Number Publication Date
US20150093839A1 true US20150093839A1 (en) 2015-04-02

Family

ID=52740540

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/043,895 Abandoned US20150093839A1 (en) 2013-10-02 2013-10-02 Methods and systems for detection of target and applications thereof
US15/465,970 Active 2034-05-25 US10989709B2 (en) 2013-10-02 2017-03-22 Methods and systems for detection of target and applications thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/465,970 Active 2034-05-25 US10989709B2 (en) 2013-10-02 2017-03-22 Methods and systems for detection of target and applications thereof

Country Status (1)

Country Link
US (2) US20150093839A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10257060B2 (en) * 2017-03-27 2019-04-09 Ca, Inc. Rendering application log data in conjunction with system monitoring

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624537A (en) * 1994-09-20 1997-04-29 The University Of British Columbia - University-Industry Liaison Office Biosensor and interface membrane
US5998588A (en) * 1995-09-01 1999-12-07 University Of Washington Interactive molecular conjugates
US20020068157A1 (en) * 2000-10-26 2002-06-06 Glaucus Proteomics B.V. Products with biofunctional coating
US20100151465A1 (en) * 2008-03-27 2010-06-17 Jingyue Ju Selective Capture and Release of Analytes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683916A (en) 1988-10-31 1997-11-04 Hemasure Inc. Membrane affinity apparatus and purification methods related thereto
US6426086B1 (en) 1998-02-03 2002-07-30 The Regents Of The University Of California pH-sensitive, serum-stable liposomes
US6258275B1 (en) 1999-10-01 2001-07-10 Ecole Polytechnique Federale De Lausanne Affinity macroligands
US6605714B2 (en) 2000-11-29 2003-08-12 Council Of Scientific And Industrial Research Thermoprecipitating polymer containing enzyme specific ligands, process for the preparation thereof, and use thereof for the separation of enzymes
US7157603B2 (en) 2001-05-14 2007-01-02 Polytag Technology Sa Method for the separation of oligomeric N-substituted (meth)acrylamide compounds and conjugates thereof which are reversibly thermally precipitating
US7371852B2 (en) 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
JP2009521672A (en) 2005-12-22 2009-06-04 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ Biomolecule preparation
AU2007262448A1 (en) 2006-04-14 2007-12-27 Interface Biologics Incorporated Grafted polymers and uses thereof
EP2294227B1 (en) * 2008-06-02 2015-08-12 GE Healthcare Bio-Sciences AB Concentration assay
WO2010006238A2 (en) 2008-07-11 2010-01-14 The Administrators Of The Tulane Educational Fund Stimulus-responsive apta-chelamers
CA2748807C (en) 2009-01-08 2019-01-29 Ge Healthcare Bio-Sciences Ab Separation method using single polymer phase systems

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624537A (en) * 1994-09-20 1997-04-29 The University Of British Columbia - University-Industry Liaison Office Biosensor and interface membrane
US5998588A (en) * 1995-09-01 1999-12-07 University Of Washington Interactive molecular conjugates
US20020068157A1 (en) * 2000-10-26 2002-06-06 Glaucus Proteomics B.V. Products with biofunctional coating
US20100151465A1 (en) * 2008-03-27 2010-06-17 Jingyue Ju Selective Capture and Release of Analytes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10257060B2 (en) * 2017-03-27 2019-04-09 Ca, Inc. Rendering application log data in conjunction with system monitoring

Also Published As

Publication number Publication date
US10989709B2 (en) 2021-04-27
US20170191992A1 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
US11021748B2 (en) Systems and methods for genetic and biological analysis
CA2837486C (en) Systems and methods for nucleic acid sequencing
Paleček et al. Magnetic beads as versatile tools for electrochemical DNA and protein biosensing
US6238927B1 (en) Reverse displacement assay for detection of nucleic acid sequences
US9399217B2 (en) Chamber free nanoreactor system
CN108779467B (en) Method for screening aptamer
EP3380607B1 (en) Purification of polymerase complexes
Zhu et al. Solid-state nanopore single-molecule sensing of DNAzyme cleavage reaction assisted with nucleic acid nanostructure
US10989709B2 (en) Methods and systems for detection of target and applications thereof
JP5759351B2 (en) Pyrophosphate detection method using boronic acid group-immobilized support
EP3327147A1 (en) Method for quantitatively profiling nucleic acids
US10359419B2 (en) Methods for detection of target using affinity binding
Abu Jalboush et al. Improving the Performance of Selective Solid-State Nanopore Sensing Using a Polyhistidine-Tagged Monovalent Streptavidin
Radadiya The Graphene Base DNA Sensing

Legal Events

Date Code Title Description
AS Assignment

Owner name: GENERAL ELECTRIC COMPANY, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POTYRAILO, RADISLAV ALEXANDROVICH;PRIS, ANDREW DAVID;NAGRAJ, NANDINI;AND OTHERS;REEL/FRAME:031325/0789

Effective date: 20130930

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION